Mariya Rozenblit

Trials

Studies that name Mariya Rozenblit as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:22 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07578116 · Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

  SWOG Cancer Research Network · recruiting · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma, Oligometastatic Breast Carcinoma · principal investigator
• Ph2
  NCT06923527 · Circulating Tumor DNA

  Yale University · recruiting · ER+ Breast Cancer · principal investigator
• N/A
  NCT06572800 · Tka Assay for CDK4/6i

  Yale University · completed · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• SWOG Network Group Operations Center of the NCTN
  U10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAWN HERSHMAN, PRIMO N. LARA · fiscal years 2014 to 2026
  Named on NCT07578116
• Genomics, Genetics and Epigenetics Research Program
  P30CA016359 · NCI · YALE UNIVERSITY · PI LAJOS PUSZTAI · fiscal years 2013 to 2026
  Named on NCT06572800